Gene · 7402
Papers3,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy. | Front Pharmacol | 2022 | 36467064 | PubTator, text mining | PubMed |
| The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial. | EBioMedicine | 2022 | 36455409 | PubTator, text mining | PubMed |
| Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases. | Cell Mol Life Sci | 2022 | 36441348 | PubTator, text mining | PubMed |
| Amorphous silica nanoparticles caused lung injury through the induction of epithelial apoptosis via ROS/Ca2+/DRP1-mediated mitochondrial fission signaling. | Nanotoxicology | 2022 | 36441139 | PubTator, text mining | PubMed |
| Early Developmental Changes of Muscle Acetylcholine Receptors Are Little Influenced by Dystrophin Absence in mdx Mouse. | Life (Basel) | 2022 | 36430996 | PubTator, text mining | PubMed |
| Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD. | Clin Transl Med | 2022 | 36424805 | PubTator, text mining | PubMed |
| Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD. | Mol Ther Nucleic Acids | 2022 | 36420212 | PubTator, text mining | PubMed |
| Disruption of cardio-pulmonary coupling in myopathies: Pathophysiological and mechanistic characterization with special emphasis on nemaline myopathy. | Front Cardiovasc Med | 2022 | 36419493 | PubTator, text mining | PubMed |
| COX7A1 enhances the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via regulating mitochondrial metabolism. | Cell Death Dis | 2022 | 36418320 | PubTator, text mining | PubMed |
| Pointed-end processive elongation of actin filaments by Vibrio effectors VopF and VopL. | Sci Adv | 2022 | 36399577 | PubTator, text mining | PubMed |
| Validation of an assessment, medical problem-oriented plan, and care plan tools for demonstrating the clinical pharmacist's activities. | Saudi Pharm J | 2022 | 36387343 | PubTator, text mining | PubMed |
| Hydrogen sulfide against preeclampsia exposure-induced oxidative mitochondrial damage in HTR-8/SVneo cells. | Front Cardiovasc Med | 2022 | 36386317 | PubTator, text mining | PubMed |
| Enhancing interaction of actin and actin-binding domain 1 of dystrophin with modulators: Toward improved gene therapy for Duchenne muscular dystrophy. | J Biol Chem | 2022 | 36372234 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction as an Underlying Cause of Skeletal Muscle Disorders. | Int J Mol Sci | 2022 | 36361713 | PubTator, text mining | PubMed |
| New Insights into Psoriasis. | Int J Mol Sci | 2022 | 36361637 | PubTator, text mining | PubMed |
| Strategies for Bottlenecks of rAAV-Mediated Expression in Skeletal and Cardiac Muscle of Duchenne Muscular Dystrophy. | Genes (Basel) | 2022 | 36360257 | PubTator, text mining | PubMed |
| MyoD-Induced Trans-Differentiation: A Paradigm for Dissecting the Molecular Mechanisms of Cell Commitment, Differentiation and Reprogramming. | Cells | 2022 | 36359831 | PubTator, text mining | PubMed |
| Cardiolipin Alterations during Obesity: Exploring Therapeutic Opportunities. | Biology (Basel) | 2022 | 36358339 | PubTator, text mining | PubMed |
| De novo and inherited variants in coding and regulatory regions in genetic cardiomyopathies. | Hum Genomics | 2022 | 36357925 | PubTator, text mining | PubMed |
| Selective degradation of tRNASer(AGY) is the primary driver for mitochondrial seryl-tRNA synthetase-related disease. | Nucleic Acids Res | 2022 | 36350636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7402/papers?page=52